Menstrual Phase Linked To Ineffective Mammograms

August 14, 1997

Menstruating women have twice the risk of false-negative mammogram results when breast cancer screening is done during the last two weeks of their menstrual cycle, according to a study in the August 15 issue of Cancer.

"Although the medical community recognizes the benefits from screening are smaller and slower to appear in younger compared to older women, we still do not know why," says Dr. Cornelia Baines, the study's principal investigator and an associate professor in the department of public health sciences. "From our research we've learned menstruation may partially explain why women under 50 years of age do not benefit from screening mammograms as much as older women."

The research involved examining data from the Canadian National Breast Screening Study collected from 8,887 menstruating women who were 40-44 years old when they entered the study. The investigators compared mammogram results of women in the follicular phase of their menstrual cycle (days 1 to 14) with those in the luteal phase of their cycle (days 15- 28).

Baines and her U of T colleagues also looked at whether the women had taken hormones in the form of oral contraceptives or replacement therapy. The analysis showed a total of 1,898 women in study had never used hormones, 6,573 women were past users and 416 were current users.

A false-negative mammogram occurs when the x-ray is read as not suspicious for cancer when in fact cancer is present. When a mammogram fails to pick up cancer, the cancer can sometimes be detected without delay if a clinical breast exam is simultaneously performed, as was the case in the Canadian National Breast Screening Study. However, sometimes breast cancer is missed by both methods.

Among women who had ever used hormones, those who had their mammogram while in the luteal phase were twice as likely to have a false-negative mammogram compared to women who had mammograms in the follicular phase. For luteal mammograms, the unadjusted odds ratio for false-negatives versus true-negatives was 2.16 and the adjusted odds ratio was 1.47, both statistically significant. In contrast, women who had never used hormones appeared to have a decreased chance of having a false-negative mammogram in the luteal phase, but this decrease was not statistically significant.

"Mammography is known to be less accurate in younger than older women," says Baines, who notes that currently many women in their 40s receive mammography without an accompanying clinical breast examination. "Without that exam, their false-negative mammograms will not be recognized and the diagnosis and treatment of breast cancer will be delayed."

"If some breast cancers are not detected by mammography, obviously the overall benefit of screening programs is likely to be reduced," explains Baines. "Our study shows there is an opportunity to improve the accuracy of mammograms by choosing to have mammograms during the first half of the menstrual cycle."

Investigators Baines and Dr. Marjan Vidmar received support from the National Cancer Institute of Canada while working on the study with Professors Gail McKeown-Eyssen and Robert Tibshirani, all of the department of public health sciences.

University of Toronto

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to